Complement C4 Prevents Viral Infection through Capsid Inactivation.

Adenovirus Infections, Human / immunology Adenoviruses, Human / immunology Animals Antibodies, Viral / metabolism Capsid / metabolism Cell Line Complement C1 / metabolism Complement C4 / metabolism Disease Models, Animal Immunity, Humoral Immunologic Factors / metabolism Mice Mice, Knockout Protein Binding Virus Inactivation
TRIM21 adenovirus complement complement C4 complement-mediated neutralization gene therapy host-pathogen humoral immunity neutralizing antibodies non-enveloped virus

Journal

Cell host & microbe
ISSN: 1934-6069
Titre abrégé: Cell Host Microbe
Pays: United States
ID NLM: 101302316

Informations de publication

Date de publication:
10 Apr 2019
Historique:
received: 04 10 2018
revised: 20 12 2018
accepted: 25 02 2019
pubmed: 31 3 2019
medline: 22 11 2019
entrez: 31 3 2019
Statut: ppublish

Résumé

The complement system is vital for anti-microbial defense. In the classical pathway, pathogen-bound antibody recruits the C1 complex (C1qC1r

Identifiants

DOI: 10.1016/j.chom.2019.02.016 PMID: 30926239 PMC: PMC6461443
pubmed: 30926239
pii: S1931-3128(19)30112-X
doi: 10.1016/j.chom.2019.02.016
pmc: PMC6461443
pii:
doi:

Substances chimiques

Antibodies, Viral 0
Complement C1 0
Complement C4 0
Immunologic Factors 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

617-629.e7

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 200594/Z/16/Z
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_U105181010
Pays : United Kingdom

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2019 MRC Laboratory of Molecular Biology. Published by Elsevier Inc. All rights reserved.

Références

J Cell Biol. 1999 Feb 22;144(4):657-72
pubmed: 10037788
Hum Gene Ther. 2000 Jan 1;11(1):151-65
pubmed: 10646647
J Immunol. 2000 Apr 15;164(8):4178-84
pubmed: 10754313
J Immunol. 2000 May 15;164(10):5313-8
pubmed: 10799893
Histochem Cell Biol. 2000 Sep;114(3):245-55
pubmed: 11083468
Nat Cell Biol. 2001 Dec;3(12):1092-100
pubmed: 11781571
J Cell Biol. 2002 Sep 16;158(6):1119-31
pubmed: 12221069
J Infect Dis. 1992 Dec;166(6):1245-50
pubmed: 1431243
J Virol. 2005 Feb;79(4):1992-2000
pubmed: 15681401
Mol Ther. 2006 Jan;13(1):108-17
pubmed: 16198149
Cell Host Microbe. 2008 Jan 17;3(1):11-9
pubmed: 18191790
J Clin Immunol. 2008 May;28 Suppl 1:S34-41
pubmed: 18404362
Pediatr Blood Cancer. 2008 Aug;51(2):293-5
pubmed: 18421721
J Immunol. 1977 Jan;118(1):28-34
pubmed: 187701
Blood. 2009 Jul 30;114(5):965-71
pubmed: 19429866
J Immunol. 2009 Jun 15;182(12):7527-38
pubmed: 19494276
Scand J Immunol. 2009 Sep;70(3):277-87
pubmed: 19703017
Cell Host Microbe. 2009 Dec 17;6(6):523-35
pubmed: 20006841
Methods Mol Biol. 2010;605:189-203
pubmed: 20072882
J Exp Med. 2010 Apr 12;207(4):793-806
pubmed: 20308361
Science. 2010 Aug 27;329(5995):1038-43
pubmed: 20798312
Proc Natl Acad Sci U S A. 2010 Nov 16;107(46):19985-90
pubmed: 21045130
Cell Host Microbe. 2011 Aug 18;10(2):105-17
pubmed: 21843868
J Virol. 2012 Aug;86(16):8482-91
pubmed: 22647693
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
J Virol. 2012 Oct;86(19):10821-8
pubmed: 22855481
Nat Methods. 2012 Jul;9(7):671-5
pubmed: 22930834
Nat Med. 2013 Apr;19(4):452-7
pubmed: 23524342
PLoS One. 2013 Apr 19;8(4):e61571
pubmed: 23620768
J Virol. 2013 Nov;87(22):12367-79
pubmed: 24027314
Nat Protoc. 2013 Nov;8(11):2281-2308
pubmed: 24157548
Science. 2014 Mar 14;343(6176):1260-3
pubmed: 24626930
J Virol. 2015 Feb;89(3):1719-30
pubmed: 25410864
Autophagy. 2015;11(8):1408-24
pubmed: 26114578
Proc Natl Acad Sci U S A. 2015 Aug 11;112(32):10014-9
pubmed: 26150489
Cell Host Microbe. 2015 Jul 8;18(1):75-85
pubmed: 26159720
J Immunol. 2016 Apr 15;196(8):3452-3459
pubmed: 26962230
Sci Rep. 2016 Nov 24;6:37457
pubmed: 27881870
Proc Natl Acad Sci U S A. 2017 Jan 17;114(3):574-579
pubmed: 28049840
Protein Cell. 2018 Jan;9(1):63-73
pubmed: 28986820
Cell. 2017 Dec 14;171(7):1692-1706.e18
pubmed: 29153837
Nat Commun. 2018 Jan 31;9(1):450
pubmed: 29386504
Proc Natl Acad Sci U S A. 2018 Oct 9;115(41):10440-10445
pubmed: 30209217
J Exp Med. 1974 Aug 1;140(2):549-65
pubmed: 4367757
Proc Natl Acad Sci U S A. 1969 Oct;64(2):520-7
pubmed: 4982356
Br J Ophthalmol. 1984 May;68(5):350-2
pubmed: 6324850
Springer Semin Immunopathol. 1983;6(4):327-47
pubmed: 6364429
J Virol. 1994 Sep;68(9):5925-32
pubmed: 7520097
Cell. 1993 Nov 5;75(3):477-86
pubmed: 8221887
Cell. 1993 Apr 23;73(2):309-19
pubmed: 8477447
Science. 1997 Feb 28;275(5304):1320-3
pubmed: 9036860
Protein Sci. 1997 Feb;6(2):263-74
pubmed: 9041627

Auteurs

Maria Bottermann (M)

Protein and Nucleic Acid Chemistry Division, Medical Research Council, Laboratory of Molecular Biology, Cambridge CB2 0QH, UK.

Stian Foss (S)

Centre for Immune Regulation (CIR) and Department of Biosciences, University of Oslo, Oslo N-0316, Norway; CIR and Department of Immunology, Rikshospitalet, Oslo University Hospital, Oslo N-0372, Norway; Department of Pharmacology, Institute of Clinical Medicine, University of Oslo and Oslo University Hospital, Oslo N-0372, Norway.

Sarah L Caddy (SL)

Protein and Nucleic Acid Chemistry Division, Medical Research Council, Laboratory of Molecular Biology, Cambridge CB2 0QH, UK.

Dean Clift (D)

Protein and Nucleic Acid Chemistry Division, Medical Research Council, Laboratory of Molecular Biology, Cambridge CB2 0QH, UK.

Laurens M van Tienen (LM)

Protein and Nucleic Acid Chemistry Division, Medical Research Council, Laboratory of Molecular Biology, Cambridge CB2 0QH, UK.

Marina Vaysburd (M)

Protein and Nucleic Acid Chemistry Division, Medical Research Council, Laboratory of Molecular Biology, Cambridge CB2 0QH, UK.

James Cruickshank (J)

Protein and Nucleic Acid Chemistry Division, Medical Research Council, Laboratory of Molecular Biology, Cambridge CB2 0QH, UK.

Kevin O'Connell (K)

Protein and Nucleic Acid Chemistry Division, Medical Research Council, Laboratory of Molecular Biology, Cambridge CB2 0QH, UK.

Jessica Clark (J)

Protein and Nucleic Acid Chemistry Division, Medical Research Council, Laboratory of Molecular Biology, Cambridge CB2 0QH, UK.

Keith Mayes (K)

Protein and Nucleic Acid Chemistry Division, Medical Research Council, Laboratory of Molecular Biology, Cambridge CB2 0QH, UK.

Katie Higginson (K)

Protein and Nucleic Acid Chemistry Division, Medical Research Council, Laboratory of Molecular Biology, Cambridge CB2 0QH, UK.

Heidrun E Lode (HE)

CIR and Department of Immunology, Rikshospitalet, Oslo University Hospital, Oslo N-0372, Norway; Department of Pharmacology, Institute of Clinical Medicine, University of Oslo and Oslo University Hospital, Oslo N-0372, Norway.

Martin B McAdam (MB)

CIR and Department of Immunology, Rikshospitalet, Oslo University Hospital, Oslo N-0372, Norway.

Inger Sandlie (I)

Centre for Immune Regulation (CIR) and Department of Biosciences, University of Oslo, Oslo N-0316, Norway; CIR and Department of Immunology, Rikshospitalet, Oslo University Hospital, Oslo N-0372, Norway.

Jan Terje Andersen (JT)

CIR and Department of Immunology, Rikshospitalet, Oslo University Hospital, Oslo N-0372, Norway; Department of Pharmacology, Institute of Clinical Medicine, University of Oslo and Oslo University Hospital, Oslo N-0372, Norway.

Leo C James (LC)

Protein and Nucleic Acid Chemistry Division, Medical Research Council, Laboratory of Molecular Biology, Cambridge CB2 0QH, UK. Electronic address: lcj@mrc-lmb.cam.ac.uk.

Articles similaires

Evaluating the efficacy of telesurgery with dual console SSI Mantra Surgical Robotic System: experiment on animal model and clinical trials.

Sudhir Prem Srivastava, Vishwajyoti Pascual Srivastava, Avinesh Singh et al.
1.00
Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell

FBXO22 inhibits colitis and colorectal carcinogenesis by regulating the degradation of the S2448-phosphorylated form of mTOR.

Minle Li, Xuan Chen, Pengfei Qu et al.
1.00
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice

Use of organic material provided by an automatic enrichment device by weaner pigs and its influence on tail lesions.

Philipp Heseker, Jeanette Probst, Stefanie Ammer et al.
1.00
Animals Tail Swine Behavior, Animal Animal Husbandry

Classifications MeSH

questionsmedicales.fr › Infection › Maladies virales › Infections à virus à ADN › Infections à Adenoviridae › Infections humaines à adénovirus › Complement C4 Prevents Viral Infection through...
questionsmedicales.fr › Virus › Virus à ADN › Adenoviridae › Mastadenovirus › Adénovirus humains › Complement C4 Prevents Viral Infection through...
questionsmedicales.fr › Eucaryotes › Animaux › Complement C4 Prevents Viral Infection through...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Globulines › Sérum-globulines › Immunoglobulines › Anticorps › Anticorps antiviraux › Complement C4 Prevents Viral Infection through...
questionsmedicales.fr › Structures virales › Virion › Nucléocapside › Capside › Complement C4 Prevents Viral Infection through...
questionsmedicales.fr › Cellules › Cellules cultivées › Lignée cellulaire › Complement C4 Prevents Viral Infection through...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines du sang › Immunoprotéines › Protéines du système du complément › Complément C1 › Complement C4 Prevents Viral Infection through...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines du sang › Immunoprotéines › Protéines du système du complément › Complément C4 › Complement C4 Prevents Viral Infection through...
questionsmedicales.fr › Techniques d'investigation › Modèles théoriques › Modèles biologiques › Modèles animaux de maladie humaine › Complement C4 Prevents Viral Infection through...
questionsmedicales.fr › Phénomènes du système immunitaire › Immunité › Immunité acquise › Immunité humorale › Complement C4 Prevents Viral Infection through...
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Effets physiologiques des médicaments › Facteurs immunologiques › Complement C4 Prevents Viral Infection through...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Rodentia › Muridae › Murinae › Souris › Complement C4 Prevents Viral Infection through...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Rodentia › Muridae › Murinae › Souris › Souris transgéniques › Souris knockout › Complement C4 Prevents Viral Infection through...
questionsmedicales.fr › Métabolisme › Liaison aux protéines › Complement C4 Prevents Viral Infection through...
questionsmedicales.fr › Phénomènes microbiologiques › Phénomènes physiologiques viraux › Inactivation virale › Complement C4 Prevents Viral Infection through...